Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C

Journal of Hepatology(2003)

引用 42|浏览10
暂无评分
摘要
Background/Aims: The CC-chemokine receptor (CCR) 5-Δ32 mutation may predispose to chronic liver disease and high level viremia in hepatitis C. However, it is unclear whether CCR5-Δ32 also affects the response to antiviral treatment.
更多
查看译文
关键词
CCR5,Hepatitis C virus,Interferon,Ribavirin,Treatment response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要